These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 8819002)
21. Obesity modestly affects inhaled anesthetic kinetics in humans. Lemmens HJ; Saidman LJ; Eger EI; Laster MJ Anesth Analg; 2008 Dec; 107(6):1864-70. PubMed ID: 19020131 [TBL] [Abstract][Full Text] [Related]
22. Development and validation of discriminating method of dissolution for fosamprenavir tablets based on in vivo data. Rossi RC; Dias CL; Bajerski L; Bergold AM; Fröehlich PE J Pharm Biomed Anal; 2011 Feb; 54(3):439-44. PubMed ID: 20943342 [TBL] [Abstract][Full Text] [Related]
23. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs. Higashino H; Hasegawa T; Yamamoto M; Matsui R; Masaoka Y; Kataoka M; Sakuma S; Yamashita S Mol Pharm; 2014 Mar; 11(3):746-54. PubMed ID: 24460473 [TBL] [Abstract][Full Text] [Related]
24. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption. George K Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411 [TBL] [Abstract][Full Text] [Related]
26. Dissolution process analysis using model-free Noyes-Whitney integral equation. Hattori Y; Haruna Y; Otsuka M Colloids Surf B Biointerfaces; 2013 Feb; 102():227-31. PubMed ID: 23010115 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of solubility, dissolution release profile and reduction in ulcerogenicity of piroxicam by inclusion complex with skimmed milk. Sanka K; Munjulury VS; Mohd AB; Diwan PV Drug Deliv; 2014 Nov; 21(7):560-70. PubMed ID: 24266528 [TBL] [Abstract][Full Text] [Related]
28. Prediction of human absorption of a trioxane antimalarial drug (CDRI 99/411) using an in-house validated in situ single-pass intestinal perfusion model. Wahajuddin ; Singh SP; Patel K; Pradhan T; Siddiqui HH; Singh SK Arzneimittelforschung; 2011; 61(9):532-7. PubMed ID: 22029231 [TBL] [Abstract][Full Text] [Related]
29. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation. Freag MS; Elnaggar YS; Abdallah OY Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765 [TBL] [Abstract][Full Text] [Related]
30. Once-a-day controlled-release dosage form of divalproex sodium II: development of a predictive in vitro drug release method. Qiu Y; Garren J; Samara E; Cao G; Abraham C; Cheskin HS; Engh KR J Pharm Sci; 2003 Nov; 92(11):2317-25. PubMed ID: 14603516 [TBL] [Abstract][Full Text] [Related]
31. In-vitro and in-vivo correlation for two gliclazide extended-release tablets. Mandal U; Ray KK; Gowda V; Ghosh A; Pal TK J Pharm Pharmacol; 2007 Jul; 59(7):971-6. PubMed ID: 17637192 [TBL] [Abstract][Full Text] [Related]
32. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353 [TBL] [Abstract][Full Text] [Related]
33. In vivo and in vitro evaluation of three controlled release principles of 6-N-cyclohexyl-2'-O-methyladenosine. Royce A; Li S; Weaver M; Shah U J Control Release; 2004 May; 97(1):79-90. PubMed ID: 15147806 [TBL] [Abstract][Full Text] [Related]
34. Dehydration kinetics of piroxicam monohydrate and relationship to lattice energy and structure. Sheth AR; Zhou D; Muller FX; Grant DJ J Pharm Sci; 2004 Dec; 93(12):3013-26. PubMed ID: 15503314 [TBL] [Abstract][Full Text] [Related]
35. Fraction of a dose absorbed estimation for structurally diverse low solubility compounds. Sugano K Int J Pharm; 2011 Feb; 405(1-2):79-89. PubMed ID: 21134428 [TBL] [Abstract][Full Text] [Related]
36. Conventional vs Mechanistic IVIVC: A Comparative Study in Establishing Dissolution Safe Space for Extended Release Formulations. Kollipara S; Ahmed T; Chougule M; Guntupalli C; Sivadasu P AAPS PharmSciTech; 2024 May; 25(5):118. PubMed ID: 38806735 [TBL] [Abstract][Full Text] [Related]
37. A Simple One-Parameter Percent Dissolved Versus Time Dissolution Equation that Accommodates Sink and Non-sink Conditions via Drug Solubility and Dissolution Volume. Polli JE AAPS J; 2022 Nov; 25(1):1. PubMed ID: 36396889 [TBL] [Abstract][Full Text] [Related]
38. Estimation of the Shleghm MR; Mircioiu C; Voicu VA; Mircioiu I; Anuta V Front Pharmacol; 2020; 11():621667. PubMed ID: 33658939 [TBL] [Abstract][Full Text] [Related]
39. Hydrogel-based matrices for controlled drug delivery of etamsylate: Prediction of El-Masry SM; Helmy SA Saudi Pharm J; 2020 Dec; 28(12):1704-1718. PubMed ID: 33424262 [TBL] [Abstract][Full Text] [Related]
40. In Vitro-In Vivo Correlations Based on In Vitro Dissolution of Parent Drug Diltiazem and Pharmacokinetics of its Metabolite. Mircioiu C; Anuta V; Mircioiu I; Nicolescu A; Fotaki N Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31315287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]